0001179110-14-008296.txt : 20140513
0001179110-14-008296.hdr.sgml : 20140513
20140513171056
ACCESSION NUMBER: 0001179110-14-008296
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140513
FILED AS OF DATE: 20140513
DATE AS OF CHANGE: 20140513
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc.
CENTRAL INDEX KEY: 0001503802
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263931704
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MERCER ROAD
CITY: NATICK
STATE: MA
ZIP: 01760
BUSINESS PHONE: 508-975-4820
MAIL ADDRESS:
STREET 1: 2 MERCER ROAD
CITY: NATICK
STATE: MA
ZIP: 01760
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brannelly Paul
CENTRAL INDEX KEY: 0001394936
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36167
FILM NUMBER: 14838296
MAIL ADDRESS:
STREET 1: C/O SIRTRIS PHARMACEUTICALS, INC.
STREET 2: 790 MEMORIAL DRIVE, SUITE 104
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2014-05-13
0
0001503802
Karyopharm Therapeutics Inc.
KPTI
0001394936
Brannelly Paul
C/O KARYOPHARM THERAPEUTICS INC.,
2 MERCER ROAD
NATICK
MA
01760
0
1
0
0
SVP, FINANCE & ADMIN, TREAS
Common Stock
2014-05-13
4
P
0
1000
28.0574
A
64636
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $28.02 to $28.20, inclusive. The reporting person undertakes to provide to Karyopharm Therapeutics Inc., any security holder of Karyopharm Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
/s/ Christopher B. Primiano as Attorney-in-Fact for Paul Brannelly
2014-05-13